Market Place
Sourcing Support
“Polpharma has invested over €35 million in a new facility to handle HPAPIs”
Over the recent years, the market for contract development and manufacturing organizations (CDMOs) has been growing at a fast c...
“Polpharma has the best equipment and team to deliver impurity-free products”
N-nitrosamine impurities have been in the news for some years now. SpeakPharma interviewed Karina Boszko, Head of API Regulator...
“Polpharma API’s ability to control particle size distribution resolves multiple formulation challenges for our clients”
This week, SpeakPharma interviews three experts from Poland’s leading pharmaceutical company, Polpharma. Dorota Pogoda, M...
